Tempest Therapeutics, Inc. Share Price
TPSTTempest Therapeutics, Inc. Stock Performance
Open $1.88 | Prev. Close $1.73 | Circuit Range N/A |
Day Range $1.88 - $2.06 | Year Range $1.52 - $12.06 | Volume 4,157 |
Average Traded $2.01 |
Tempest Therapeutics, Inc. Share Price Chart
About Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.
Tempest Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Apr-26 | $1.88 | $2.02 | +0.00% |
30-Apr-26 | $1.88 | $2.02 | +16.76% |
29-Apr-26 | $1.70 | $1.73 | +2.37% |
28-Apr-26 | $1.72 | $1.69 | -1.74% |
27-Apr-26 | $1.80 | $1.72 | -6.52% |
24-Apr-26 | $1.80 | $1.84 | +3.37% |
23-Apr-26 | $1.80 | $1.78 | -4.04% |
FAQs on Tempest Therapeutics, Inc. Share Price
Can I buy Tempest Therapeutics, Inc. shares in India?
What is the share price of Tempest Therapeutics, Inc.?
What is the 5 year returns of Tempest Therapeutics, Inc.?
What are the high & low stock price of Tempest Therapeutics, Inc. today?
What is the 52-week high and low of Tempest Therapeutics, Inc. stock?